Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why Do A&D Customers Care About Sustainability? with Ben Kraft of Clarus

On today’s episode of Glass is in Session, we brought Ben Kraft, also known as the ‘Glass Man Extraordinaire,’ into the studio. Kraft, an A&D sales representative for Clarus, gives his sales and manufacturing insight on the reasons for and the impacts of green design on company-client relationships. Kraft helps answer these questions as…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

On today’s episode of Glass is in Session, we brought Ben Kraft, also known as the ‘Glass Man Extraordinaire,’ into the studio. Kraft, an A&D sales representative for Clarus, gives his sales and manufacturing insight on the reasons for and the impacts of green design on company-client relationships.

Kraft helps answer these questions as we unpack the customers in Clarus’ three key industries (healthcare, higher education, and corporate America), and what is pushing them to buy green. Is it because the common culture is really becoming more interested in saving the environment, or is it from motivation to take advantage of green initiatives like LEED, BREEAM, and the Living Building Challenge? Are certifications like declare labels or environmental product declarations just a simple requirement for these customers, or do they just prefer to choose from sustainable products?

Kraft thinks the two biggest motivators are wellness and price points. Health, wellness and safety are major factors, especially within fields like healthcare and education, considering the people in those buildings are near these materials every day for extensive periods of time. Same things goes for the back end; B2B clients want to know that the products they’re purchasing promote the wellness and safety of the designers and manufacturers creating them. But it’s difficult to deny price point is a big motivator. Budgets are always tight, and finding a lower cost solution is always appealing. What Kraft points out, though, is that a high quality sustainable product won’t come cheap, and customers aren’t being dissuaded by the price.

How do we convince the client-side of the AEC industry to keep using sustainable products, how does educating the end user encourage more B2B sales, and where do Clarus’ Glassboards fit into all of this? We discuss the certifications that these products have, what they mean to the companies that employ them, and what this means for our future on this episode of Glass is in Session.

For more episodes of Glass is in Session, head to Clarus’ site.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512